Australian Drug Maker Jumps 51% After Winning FDA Approval

(Bloomberg) -- Clinuvel Pharmaceuticals Ltd. surged the most in five years after the U.S. Food and Drug Administration approved its treatment for a rare skin disorder that causes sensitivity to lig...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.